Zuprevo

SRD treatment you can count on!

Zuprevo contains Tildipirosin, a 16-membered macrolide. Tildipirosin acts by inhibiting protein synthesis of the bacterial ribosome. It binds with the 23S ribosomal ribonucleic acid of the 50S ribosomal subunit. It is bacteriostatic or bactericidal depending on the bacterial species, individual strain and drug concentrations.

• 14 days of activity in the lungs - Long duration of action for at least 14 days after a single intramuscular injection.
• 1 single dose 1ml/10kg bw - Zuprevo is quick and convenient to administer. Zuprevo is fast acting and reaches maximum blood serum concentrations in 23 minutes.
  
• 4 label pathogens - Zuprevo provides treatment against the primary pathogens associated with SRD: Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis.
• 9 days withdrawal - Rapid elimination means a short withdrawal period.

For more information see Description.